
Sharmila Gollamudi Landau
Examiner (ID: 4076)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1653, 1611, 1616 |
| Total Applications | 607 |
| Issued Applications | 112 |
| Pending Applications | 58 |
| Abandoned Applications | 440 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20663666
[patent_doc_number] => 12605416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Compositions and methods for the treatment of skin diseases and conditions including eczema
[patent_app_type] => utility
[patent_app_number] => 19/003326
[patent_app_country] => US
[patent_app_date] => 2024-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7221
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19003326
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/003326 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Dec 26, 2024 | Issued |
Array
(
[id] => 19232157
[patent_doc_number] => 20240189348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/583611
[patent_app_country] => US
[patent_app_date] => 2024-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/583611 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | Feb 20, 2024 | Pending |
Array
(
[id] => 18972300
[patent_doc_number] => 20240052392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/491555
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -103
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491555 | CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION | Oct 19, 2023 | Pending |
Array
(
[id] => 18893864
[patent_doc_number] => 20240009349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PCL PATCH TISSUE REGENERATION SCAFFOLD AND METHOD FOR MANUFACTURING SAME
[patent_app_type] => utility
[patent_app_number] => 18/370878
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370878
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370878 | PCL patch tissue regeneration scaffold and method for manufacturing same | Sep 20, 2023 | Issued |
Array
(
[id] => 18707585
[patent_doc_number] => 20230330162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PRODUCT COMPRISING PROBIOTICS AND ISOMALTULOSE AND METHOD OF ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/134210
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134210 | PRODUCT COMPRISING PROBIOTICS AND ISOMALTULOSE AND METHOD OF ITS PRODUCTION | Apr 12, 2023 | Pending |
Array
(
[id] => 18567436
[patent_doc_number] => 20230257769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => TRANSGENIC PHOTORECEPTORS AND THEIR USE IN VISION TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/098328
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098328 | TRANSGENIC PHOTORECEPTORS AND THEIR USE IN VISION TREATMENT | Jan 17, 2023 | Abandoned |
Array
(
[id] => 18193915
[patent_doc_number] => 20230047434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/894936
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894936 | COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE | Aug 23, 2022 | Pending |
Array
(
[id] => 19140430
[patent_doc_number] => 20240139213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/867512
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867512 | VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME | Jul 17, 2022 | Pending |
Array
(
[id] => 17960289
[patent_doc_number] => 20220340869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM FETAL APPENDAGE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/850041
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850041 | CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM FETAL APPENDAGE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION | Jun 26, 2022 | Abandoned |
Array
(
[id] => 18109845
[patent_doc_number] => 20230002725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/662289
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662289 | SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF | May 5, 2022 | Abandoned |
Array
(
[id] => 17792520
[patent_doc_number] => 20220251611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => BENZALDEHYDE PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/730360
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730360 | BENZALDEHYDE PRODUCTION METHOD | Apr 26, 2022 | Pending |
Array
(
[id] => 19232184
[patent_doc_number] => 20240189375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => COMPOSITION COMPRISING A EUKARYOTIC MICROALGAE OR AN EXTRACT THEREOF FOR USE IN THE TREATMENT OF A VIRAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/554492
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554492
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554492 | COMPOSITION COMPRISING A EUKARYOTIC MICROALGAE OR AN EXTRACT THEREOF FOR USE IN THE TREATMENT OF A VIRAL DISEASE | Apr 12, 2022 | Pending |
Array
(
[id] => 17774929
[patent_doc_number] => 20220241278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => INHALABLE IMATINIB FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/719042
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719042 | INHALABLE IMATINIB FORMULATION | Apr 11, 2022 | Pending |
Array
(
[id] => 18160379
[patent_doc_number] => 20230026971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => EXTRACELLULAR MATRIX STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 17/710552
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710552 | EXTRACELLULAR MATRIX STRUCTURES | Mar 30, 2022 | Pending |
Array
(
[id] => 17658446
[patent_doc_number] => 20220178911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Synthetic Lethality Screening Platform for Cells Undergoing ALT
[patent_app_type] => utility
[patent_app_number] => 17/681714
[patent_app_country] => US
[patent_app_date] => 2022-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681714 | Synthetic Lethality Screening Platform for Cells Undergoing ALT | Feb 25, 2022 | Abandoned |
Array
(
[id] => 18970401
[patent_doc_number] => 20240050493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => STRAINS, COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/260425
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260425
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260425 | STRAINS, COMPOSITIONS AND METHODS OF USE | Dec 28, 2021 | Pending |
Array
(
[id] => 17480590
[patent_doc_number] => 20220088094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/502716
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502716 | PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE | Oct 14, 2021 | Abandoned |
Array
(
[id] => 18366351
[patent_doc_number] => 20230147942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING NEW LACTOBACILLUS PLANTARUM KC3 STRAIN AND LEONURUS JAPONICUS EXTRACT AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING RESPIRATORY DISEASE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/915306
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915306 | PHARMACEUTICAL COMPOSITION COMPRISING NEW LACTOBACILLUS PLANTARUM KC3 STRAIN AND LEONURUS JAPONICUS EXTRACT AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING RESPIRATORY DISEASE AND USE THEREOF | Aug 23, 2021 | Pending |
Array
(
[id] => 17579081
[patent_doc_number] => 20220135936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => BREVUNDIMONAS STRAIN AS ENDOSYMBIONT OF VERTICILLIUM DAHLIAE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/328089
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328089 | BREVUNDIMONAS STRAIN AS ENDOSYMBIONT OF VERTICILLIUM DAHLIAE AND USE THEREOF | May 23, 2021 | Abandoned |
Array
(
[id] => 17020900
[patent_doc_number] => 20210244771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHODS AND MATERIALS FOR TREATING NERVE INJURIES AND NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/245935
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245935 | METHODS AND MATERIALS FOR TREATING NERVE INJURIES AND NEUROLOGICAL DISORDERS | Apr 29, 2021 | Abandoned |